Biocult


Biocult is a leading provider of contract manufacturing and research services, specializing in antibodies, assays, and ELISA kits. Since being acquired by Hycult Biotechnology B.V. in June 2019, they have expanded their capabilities and product offerings. With over 25 years of experience, Biocult offers high-quality antibody production, assay manufacturing, and contract research services, supporting life science and diagnostic companies facing capacity and expertise shortages. They operate under strict quality standards including EN ISO13485:2016 and GMP, and are committed to delivering personalized, efficient, and innovative solutions to their clients.

Industries

Biotechnology
Medical Device
Biotechnology Research

Nr. of Employees

small (1-50)


Products

Custom-manufactured monoclonal antibodies

Custom production of monoclonal antibodies for research, preclinical and diagnostic use with capacity scaling from milligrams to grams and associated QC testing.

Custom assays and assay components

Complete assays or individual components (buffers, standards, tracers, conjugates, plates) manufactured to specification, available in solution or freeze-dried formats and accompanied by stability and batch testing.

Verification & validation

End-to-end Verification and Validation (V&V) services for in vitro diagnostics intended for the EU (IVDR) and other major markets including the USA (FDA).

Verification & validation for pharma-related IVDs

Full verification and validation aligned with global regulatory requirements for treatment monitoring, companion, and complementary diagnostics.

Assay manufacturing

Professional assay manufacturing services for research-use-only (RUO) and IVD applications, transforming validated assay concepts into reliable, scalable products.

Immunoassay development

Custom, plate-based immunoassay development services specializing in transforming biomarker concepts into robust diagnostic solutions.

View All Products

Services

Outsourced production of monoclonal antibodies including process development, upscaling and QC testing for research, preclinical and diagnostic uses.

End-to-end assay development from feasibility and optimization to validated assays for research or IVD applications, including robustness and specificity testing.

Manufacture of complete assays and individual components (buffers, standards, tracers, conjugates, plates) with options for solution or freeze-dried formats and batch release testing.

Label-free real-time measurement of binding kinetics, quantitation and antibody pairing using bio-layer interferometry assays; accepts crude or unpurified samples.

Application-specific testing including flow cytometry, western blot, ELISA, reproducibility, recovery, intra/inter variation and stability assessments to define product specifications.

Advisory services covering production planning, experimental design, specification setting and pre-project consultancy prior to outsourcing manufacturing or development work.

Expertise Areas

  • Monoclonal antibody production and upscaling
  • Assay development and IVD assay manufacturing
  • Analytical characterization of biomolecular interactions
  • Quality management and regulatory compliance (ISO 13485, GMP, GLP)
  • Show More (1)

Key Technologies

  • Monoclonal antibody production (hybridoma and recombinant systems)
  • Mammalian cell culture (CHO, BHK, hybridoma, transfectomas)
  • Bio-layer interferometry (label-free kinetic/affinity analysis)
  • Flow cytometry
  • Show More (4)

News & Updates

Uden, The Netherlands, June 2019 – Mr. Ronald de Niet announces the acquisition of Biocult, expanding Hycult Biotech's capabilities.

Biocult joins the CULT family, enhancing collaboration and product range.

Biocult has been EN ISO13485:2016 certified since 2008, ensuring high quality and compliance.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.